Press release
Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2017
This report provides information on the microbiome based therapeutic development dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the company’s information involved in the therapeutic development of the products.
Microbiome is the highly growing fields in the biopharmaceutical industry. The therapeutics is used across many therapy areas. Major therapy areas focused by pipeline drugs for microbiome are Central Nervous System, Dermatology, Gastrointestinal, Metabolic Disorders, Infectious Disease, Ophthalmology and Ear Nose Throat Disorders. There are total 70+ drugs in pipeline out of which 2 products is in Phase II/III, 8 products in Phase II, 10 product are in Phase I, 1 product is in Phase 0. Around 30+ products are in Pre-clinical, 18 products are in Discovery stage of development and 3 products are in the unknown stage of development. Companies have also gone in collaboration with different partners.
Reports Highlights
Microbiome-based therapeutic pipeline scenario
Collaborations & partnering deals
Current Prominent Research Areas and Key Players
Pipeline product profiles focusing on Microbiome-based Technologies
Licensing opportunities
Market Drivers and Barriers
Scope of the report
Overview of the global Microbiome-based therapeutic pipeline scenario, products, and associated companies information
Coverage of global Microbiome-based therapeutic products under development
Competitive landscape of products for key players and related indications
Coverage of licensors, collaborators and development partners, deal terms and deal values estimation
Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities
Highlights of licensing & collaboration opportunities and funding details
Highlights of latest Microbiome-based technologies
Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis
For more details, pricing and sample pages please write to us at info@delveinsight.com
About DelveInsight
DelveInsight is a Business Consultant company and serves as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios, and companies.
DelveInsight business research,
A20, Sector 7, Near to Maxfort. School,
Dwarka
New Delhi-110077, India
Tel: +91-11-4568 9769 | +91 9650213330
Email: info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2017 here
News-ID: 514973 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Microbiome
Microbiome Sequencing Service Market Expanding Rapidly with Advances in Microbio …
Market Overview
The microbiome sequencing service market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to reach USD 4.64 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Microbiome Sequencing Service Market from 2025 to 2032. This study provides reliable global and regional projections,…
Global Microbiome Market | Global Microbiome Industry | Global Microbiome Market …
The microbiome market comprises of sales of bioactive molecules and linked products which are utilized as immunotherapeutic agents in pharmaceuticals industry. The microbiome market is principally engaged in the improvement and sales of such bioactive products which are utilized as immunotherapy for a wide variability of conditions such as infectious syndromes, endocrine & metabolic disorders, inflammatory conditions, cancer, irritable bowel syndrome, neurological syndromes, hematological disorders and cardiovascular sickness as well.
According…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 29th January : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Improved microbiome sequencing capabilities are likely to boost the global micro …
According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.
Request for sample report: https://www.persistencemarketresearch.com/samples/7990
Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 1st November : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
